Clinical efficacy and safety of cefepime in febrile neutropenic patients with lung cancer
β Scribed by Masaki Fujita; Hiroshi Ouchi; Yuichi Inoue; Ichiro Inoshima; Tsukasa Ohshima; Chikara Yoshimura; Hiroshi Wataya; Masayuki Kawasaki; Shoji Tokunaga; Yoichi Nakanishi; Lung Oncology Group in Kyushu (LOGIK)
- Publisher
- Springer
- Year
- 2010
- Tongue
- English
- Weight
- 160 KB
- Volume
- 16
- Category
- Article
- ISSN
- 1341-321X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract ## BACKGROUND The objective of the current study was to compare the efficacy and safety of imipenem and cefepime in the treatment of adult patients with cancer who had fever and neutropenia requiring hospitalization according to Infectious Disease Society of America criteria. ## METHO
## Abstract Amikacin (600 mg/m^2^/day IV) and ticarcillin (12 gm/m^2^/day IV) were administered to 38 children with cancer, neutropenia (< 1,000 PMN/mm^3^), and fever (β₯ 38Β°C) during 46 febrile episodes. Sixtyβone percent of the children were severely neutropenic (<200 PMN/mm^3^). Febrile episodes